Merck KGaA and Qualcomm have put money into Medisafe, which is aiming to solve the problem of patients not adhering to their medication.
Israel-based digital health company Medisafe yesterday received $14.5m in series B funding from a consortium that included M Ventures, the corporate venturing unit of pharmaceutical firm Merck KGaA.
Qualcomm Ventures, the investment arm of chip maker Qualcomm, also took part alongside Octopus Ventures, which led the round, Pitango Venture Capital, 7wire Ventures, Lool Ventures, Triventures and Eyal Gura.
Medisafe operates a cloud-based platform that engages patients through educational videos, coupons and motivational messages based on the user’s needs to help…
